Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.

Joensuu K, Hagström J, Leidenius M, Haglund C, Andersson LC, Sariola H, Heikkilä P.

Virchows Arch. 2011 Jul;459(1):31-9. doi: 10.1007/s00428-011-1096-8. Epub 2011 Jun 3.

PMID:
21638011
2.

Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.

Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, Kung HF, Song LB, Zeng MS.

Mol Cancer. 2011 Jan 28;10(1):10. doi: 10.1186/1476-4598-10-10.

3.

Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue.

Häyry V, Mäkinen LK, Atula T, Sariola H, Mäkitie A, Leivo I, Keski-Säntti H, Lundin J, Haglund C, Hagström J.

Br J Cancer. 2010 Mar 2;102(5):892-7. doi: 10.1038/sj.bjc.6605544. Epub 2010 Feb 9.

4.

Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.

Joensuu K, Heikkilä P, Andersson LC.

Cancer Lett. 2008 Jun 28;265(1):76-83. doi: 10.1016/j.canlet.2008.02.022. Epub 2008 Mar 19.

PMID:
18355956
5.

[Expression and significance of Bmi-1 in breast cancer].

Feng Y, Song LB, Guo BH, Liao WT, Li MZ, Liu WL, Zeng MS, Zhang L.

Ai Zheng. 2007 Feb;26(2):154-7. Chinese.

PMID:
17298744
6.

High expression of maspin is associated with early tumor relapse in breast cancer.

Joensuu KM, Leidenius MH, Andersson LC, Heikkilä PS.

Hum Pathol. 2009 Aug;40(8):1143-51. doi: 10.1016/j.humpath.2009.02.006. Epub 2009 May 8.

PMID:
19427667
7.

Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.

Silva J, García JM, Peña C, García V, Domínguez G, Suárez D, Camacho FI, Espinosa R, Provencio M, España P, Bonilla F.

Clin Cancer Res. 2006 Dec 1;12(23):6929-36.

8.

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1.

Arnes JB, Collett K, Akslen LA.

Histopathology. 2008 Feb;52(3):370-80. doi: 10.1111/j.1365-2559.2007.02957.x.

PMID:
18269588
9.

Cancer stem cell marker Bmi-1 expression is associated with basal-like phenotype and poor survival in breast cancer.

Wang Y, Zhe H, Ding Z, Gao P, Zhang N, Li G.

World J Surg. 2012 May;36(5):1189-94. doi: 10.1007/s00268-012-1514-3.

PMID:
22366984
10.

Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.

Hoffmann MJ, Engers R, Florl AR, Otte AP, Muller M, Schulz WA.

Cancer Biol Ther. 2007 Sep;6(9):1403-12.

PMID:
18637271
11.

Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer.

Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW.

Breast. 2004 Oct;13(5):383-8.

PMID:
15454193
12.

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.

Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS.

Clin Cancer Res. 2005 Mar 15;11(6):2111-22. Erratum in: Clin Cancer Res. 2015 May 1;21(9):2190-1.

13.

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.

van Nes JG, de Kruijf EM, Putter H, Faratian D, Munro A, Campbell F, Smit VT, Liefers GJ, Kuppen PJ, van de Velde CJ, Bartlett JM.

Breast Cancer Res Treat. 2012 May;133(1):49-59. doi: 10.1007/s10549-011-1684-y. Epub 2011 Jul 28.

PMID:
21796367
14.

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

Du J, Li L, Ou Z, Kong C, Zhang Y, Dong Z, Zhu S, Jiang H, Shao Z, Huang B, Lu J.

Breast Cancer Res Treat. 2012 Jan;131(1):65-73. doi: 10.1007/s10549-011-1396-3. Epub 2011 Apr 5. Erratum in: Breast Cancer Res Treat. 2016 Apr;156(3):609-10.

PMID:
21465172
15.
16.

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.

Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL, Li MZ, Zhang L, Kang TB, Fu LW, Huang WL, Xia YF, Tsao SW, Li M, Band V, Band H, Shi QH, Zeng YX, Zeng MS.

J Clin Invest. 2009 Dec;119(12):3626-36. doi: 10.1172/JCI39374. Epub 2009 Nov 2.

17.

Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells.

Liu ZG, Liu L, Xu LH, Yi W, Tao YL, Tu ZW, Li MZ, Zeng MS, Xia YF.

Oncol Rep. 2012 Apr;27(4):1116-22. doi: 10.3892/or.2011.1615. Epub 2011 Dec 30.

18.

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkilä P, Joensuu H.

Breast Cancer Res. 2011 Sep 13;13(5):R87. doi: 10.1186/bcr2944.

19.

Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer.

Martin TA, Goyal A, Watkins G, Jiang WG.

Ann Surg Oncol. 2005 Jun;12(6):488-96. Epub 2005 Apr 19.

PMID:
15864483
20.

Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B.

Cancer. 2005 Apr 15;103(8):1631-43.

Supplemental Content

Support Center